Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin (SAIL)
This study is currently recruiting participants.
Verified August 2012 by University of Manitoba
Study NCT01628445   Information provided by University of Manitoba

First Received on June 21, 2012.   Last Updated on August 14, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 2 Diabetes
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
liraglutide
placebo injection
Additional drug interventions recognized in this trial
Glucagon-Like Peptide 1
Insulin
More general drug interventions related to this trial
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Hypoglycemic Agents
Incretins
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University of Manitoba
Novo Nordisk


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services